COPD: Novel Therapeutics and Management Strategies

Sept. 1, 2010 - PRLog -- It can be a challenge to build a successful pipeline for a disease that, as yet, has no cure and where managing the symptoms is the only available course of action.  The first part of SMi’s 2nd annual COPD: Novel Therapeutics and Management Strategies, taking place 17th & 18th November, is aimed at learning the lessons from companies who have had success at building such a pipeline.

For more information visit our website:
http://www.smi-online.co.uk/2010copd28.asp

Taking place on World COPD Day in Munich, the conference will also consider new approaches and targets for novel COPD therapeutics, COPD in emerging markets, conducting clinical studies for COPD, biomarkers and animal models.

Highlights of the conference agenda include:

Emerging opportunities to address COPD in Asia
•   Approaches to understanding COPD in Asia
•   Partnerships established for translational science programmes
•   AstraZeneca's emerging portfolio in Asia
Deborah Hartman, Vice President Respiratory & Inflammation Research, AstraZeneca

Partnering: moving new ideas for COPD into new products
•   Why is partnering so important for developing COPD products?
•   Examples of partnering in COPD product development
•   Trends and changes in the partnering process
Christopher Meade, Head Global Licensing Respiratory, Boehringer Ingelheim

Novel therapeutics for acute exacerbations of COPD
•   Models for acute exacerbations
•   Identifying potential novel therapeutics
•   Assessment in the clinic
Liz Hardaker, Research Investigator I, Novartis

Innovative design and analysis strategies to optimise success in COPD trials
•   Efficient design/analysis strategies in early phase PoC studies
•   Dealing with uncertainty in endpoints/biomarkers
•   Benefit and application of adaptive designs
Nigel Dallow, Director of Statistics, Discovery Biometrics Respiratory, GlaxoSmithKline

For more information visit our website:
http://www.smi-online.co.uk/2010copd28.asp

# # #

SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information